Acme United Corp

Acme United insider sales: COO Brian Olschan’s recent 4,833‑share sale at $42 shows routine liquidity, not panic, while the company’s AU‑101, AU‑202, AU‑303 drug programs move toward key FDA milestones—watch how these trades and clinical progress sh…

Acme United’s insider moves: COO Brian Olschan’s mixed buy‑sell trades reveal confidence and short‑term liquidity needs, yet little impact on market value.